Marshall,
Found this at the MF ATIS boards:
Subject: Re: ATIS Earnings Potential
Date: Mon, Dec 15, 1997 21:00 EST
From: Rkta
If you are looking for a analyst view, this is Morgan stanley dean witters take,
dated 09/10/97:
Sales of the company's first marketed product, Dermagraft T.C., launched in April for the treatment of full thickness burns, were $450,000, well above our $263,000 forecast. We anticipate launch of Dermagraft in 1998 with world wide revenues exceeding $450 million in 2001. This provides revenues to ATIS approaching $115 million in 2001, by our estimates, based on its 50/50 JV with Smith & Nephew, leading to a fully taxed EPS of
$1.40 in that year. Our 12 month target is $20 based on a 28x multiple on our 2001 EPS estimate of $1.40 discounted at 25% over three years.
So if you agree with these numbers, and your looking for $60 to $80 a share your going to hav't to wait till 2001. Not a problem, I'll wait. ATIS is # 1
(end repost)
Regards,
Dennis |
